Beyond Operating Income vs Selling General Administrative Analysis

DOCKF Stock

USD 0.02 0 22.70%

Beyond Medical financial indicator trend analysis is way more than just evaluating Beyond Medical Techn prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Beyond Medical Techn is a good investment. Please check the relationship between Beyond Medical Operating Income and its Selling General Administrative accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Beyond Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

Operating Income vs Selling General Administrative

Operating Income vs Selling General Administrative Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Beyond Medical Techn Operating Income account and Selling General Administrative. At this time, the significance of the direction appears to have pay attention.

The correlation between Beyond Medical's Operating Income and Selling General Administrative is -0.98. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of Beyond Medical Technologies, assuming nothing else is changed. The correlation between historical values of Beyond Medical's Operating Income and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Beyond Medical Technologies are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Operating Income i.e., Beyond Medical's Operating Income and Selling General Administrative go up and down completely randomly.

Correlation Coefficient

-0.98

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Operating Income

Operating Income is the amount of profit realized from Beyond Medical Techn operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Beyond Medical Technologies is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Selling General Administrative

Most indicators from Beyond Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Beyond Medical Techn current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Beyond Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

The current Discontinued Operations is estimated to decrease to about 122.5 K. The current Selling General Administrative is estimated to decrease to about 178.9 K

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	173.1K	63.6K	73.2K	96.7K
Total Operating Expenses	3.0M	836.9K	548.5K	521.1K

Reconciled Depreciation Total Operating Expenses

Beyond Medical fundamental ratios Correlations

	Total Current Liabilities	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Other Current Liab	Total Stockholder Equity	Cash	Non Current Assets Total	Other Assets	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Short Term Investments	Capital Stock	Property Plant And Equipment Net	Capital Lease Obligations	Property Plant And Equipment Gross
Total Current Liabilities		-0.71	0.23	0.33	-0.67	-0.76	-0.34	-0.35	-0.06	0.51	-0.05	0.06	-0.21	0.16	-0.1	0.25	0.38	-0.11	0.01	-0.05	-0.03	0.17	0.19	-0.26	-0.18	0.12
Net Tangible Assets	-0.71		-0.38	0.18	0.82	0.94	0.54	0.75	0.12	-0.32	0.1	-0.23	0.53	-0.07	0.07	-0.5	-0.28	0.34	0.27	0.1	0.0	-0.13	0.03	-0.04	-0.04	0.02
Retained Earnings	0.23	-0.38		-0.09	-0.02	-0.17	-0.95	-0.12	0.85	-0.29	0.87	0.97	0.39	0.91	0.02	0.93	-0.62	-0.96	-0.82	0.87	0.91	0.94	-0.87	0.66	0.86	-0.86
Accounts Payable	0.33	0.18	-0.09		0.24	0.12	0.11	0.65	0.16	-0.1	0.14	-0.18	0.57	0.1	0.43	-0.28	-0.01	0.25	0.09	0.14	0.03	0.03	0.02	0.14	0.01	0.13
Net Receivables	-0.67	0.82	-0.02	0.24		0.88	0.23	0.86	0.46	-0.69	0.43	0.09	0.77	0.15	0.23	-0.29	-0.63	0.08	-0.01	0.43	0.35	0.1	-0.36	0.37	0.39	-0.33
Total Current Assets	-0.76	0.94	-0.17	0.12	0.88		0.38	0.72	0.33	-0.39	0.31	0.01	0.62	0.09	0.29	-0.31	-0.41	0.16	0.02	0.31	0.23	0.03	-0.19	0.19	0.23	-0.21
Common Stock	-0.34	0.54	-0.95	0.11	0.23	0.38		0.29	-0.7	0.17	-0.72	-0.89	-0.2	-0.82	0.06	-0.94	0.54	0.95	0.8	-0.72	-0.78	-0.86	0.79	-0.55	-0.73	0.77
Property Plant Equipment	-0.35	0.75	-0.12	0.65	0.86	0.72	0.29		0.36	-0.6	0.34	-0.1	0.86	0.15	0.23	-0.41	-0.39	0.23	0.12	0.34	0.21	0.06	-0.18	0.29	0.2	-0.08
Total Assets	-0.06	0.12	0.85	0.16	0.46	0.33	-0.7	0.36		-0.47	1.0	0.89	0.77	0.92	0.21	0.66	-0.81	-0.79	-0.74	1.0	0.99	0.91	-0.91	0.71	0.91	-0.91
Other Current Liab	0.51	-0.32	-0.29	-0.1	-0.69	-0.39	0.17	-0.6	-0.47		-0.47	-0.26	-0.63	-0.28	0.02	-0.07	0.64	0.25	0.23	-0.47	-0.41	-0.26	0.57	-0.74	-0.58	0.35
Total Stockholder Equity	-0.05	0.1	0.87	0.14	0.43	0.31	-0.72	0.34	1.0	-0.47		0.9	0.76	0.93	0.2	0.68	-0.8	-0.8	-0.76	1.0	0.99	0.92	-0.91	0.71	0.91	-0.92
Cash	0.06	-0.23	0.97	-0.18	0.09	0.01	-0.89	-0.1	0.89	-0.26	0.9		0.4	0.89	0.12	0.9	-0.69	-0.95	-0.86	0.9	0.95	0.93	-0.9	0.65	0.9	-0.94
Non Current Assets Total	-0.21	0.53	0.39	0.57	0.77	0.62	-0.2	0.86	0.77	-0.63	0.76	0.4		0.62	0.25	0.1	-0.65	-0.28	-0.32	0.76	0.66	0.55	-0.59	0.58	0.6	-0.51
Other Assets	0.16	-0.07	0.91	0.1	0.15	0.09	-0.82	0.15	0.92	-0.28	0.93	0.89	0.62		-0.02	0.82	-0.61	-0.88	-0.73	0.93	0.93	0.99	-0.81	0.57	0.78	-0.81
Common Stock Shares Outstanding	-0.1	0.07	0.02	0.43	0.23	0.29	0.06	0.23	0.21	0.02	0.2	0.12	0.25	-0.02		-0.07	-0.1	0.09	-0.3	0.19	0.18	-0.02	-0.21	0.41	0.35	-0.18
Other Current Assets	0.25	-0.5	0.93	-0.28	-0.29	-0.31	-0.94	-0.41	0.66	-0.07	0.68	0.9	0.1	0.82	-0.07		-0.39	-0.96	-0.79	0.68	0.76	0.87	-0.72	0.52	0.7	-0.72
Other Stockholder Equity	0.38	-0.28	-0.62	-0.01	-0.63	-0.41	0.54	-0.39	-0.81	0.64	-0.8	-0.69	-0.65	-0.61	-0.1	-0.39		0.61	0.6	-0.8	-0.79	-0.61	0.87	-0.62	-0.8	0.86
Total Liab	-0.11	0.34	-0.96	0.25	0.08	0.16	0.95	0.23	-0.79	0.25	-0.8	-0.95	-0.28	-0.88	0.09	-0.96	0.61		0.86	-0.8	-0.86	-0.92	0.86	-0.6	-0.8	0.84
Deferred Long Term Liab	0.01	0.27	-0.82	0.09	-0.01	0.02	0.8	0.12	-0.74	0.23	-0.76	-0.86	-0.32	-0.73	-0.3	-0.79	0.6	0.86		-0.76	-0.8	-0.76	0.88	-0.68	-0.81	0.85
Net Invested Capital	-0.05	0.1	0.87	0.14	0.43	0.31	-0.72	0.34	1.0	-0.47	1.0	0.9	0.76	0.93	0.19	0.68	-0.8	-0.8	-0.76		0.99	0.92	-0.91	0.71	0.91	-0.91
Net Working Capital	-0.03	0.0	0.91	0.03	0.35	0.23	-0.78	0.21	0.99	-0.41	0.99	0.95	0.66	0.93	0.18	0.76	-0.79	-0.86	-0.8	0.99		0.93	-0.93	0.7	0.93	-0.95
Short Term Investments	0.17	-0.13	0.94	0.03	0.1	0.03	-0.86	0.06	0.91	-0.26	0.92	0.93	0.55	0.99	-0.02	0.87	-0.61	-0.92	-0.76	0.92	0.93		-0.82	0.58	0.8	-0.83
Capital Stock	0.19	0.03	-0.87	0.02	-0.36	-0.19	0.79	-0.18	-0.91	0.57	-0.91	-0.9	-0.59	-0.81	-0.21	-0.72	0.87	0.86	0.88	-0.91	-0.93	-0.82		-0.83	-0.96	0.93
Property Plant And Equipment Net	-0.26	-0.04	0.66	0.14	0.37	0.19	-0.55	0.29	0.71	-0.74	0.71	0.65	0.58	0.57	0.41	0.52	-0.62	-0.6	-0.68	0.71	0.7	0.58	-0.83		0.89	-0.62
Capital Lease Obligations	-0.18	-0.04	0.86	0.01	0.39	0.23	-0.73	0.2	0.91	-0.58	0.91	0.9	0.6	0.78	0.35	0.7	-0.8	-0.8	-0.81	0.91	0.93	0.8	-0.96	0.89		-0.89
Property Plant And Equipment Gross	0.12	0.02	-0.86	0.13	-0.33	-0.21	0.77	-0.08	-0.91	0.35	-0.92	-0.94	-0.51	-0.81	-0.18	-0.72	0.86	0.84	0.85	-0.91	-0.95	-0.83	0.93	-0.62	-0.89

Click cells to compare fundamentals

Beyond Medical Account Relationship Matchups

Beyond Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Current Liabilities	146.8K	274.3K	413.3K	346.9K	430.4K	332.3K
Net Tangible Assets	8.2M	3.5M	1.5M	1.5M	1.4M	2.7M
Retained Earnings	(16.7M)	(22.3M)	(25.3M)	(25.6M)	(26.1M)	(27.4M)
Accounts Payable	59.1K	186.8K	174.6K	86.8K	104.1K	139.6K
Net Receivables	62.4K	166.2K	115.7K	38.6K	2.9K	0.0
Total Current Assets	3.4M	1.2M	1.8M	579.3K	95.6K	90.9K
Common Stock	18.0M	18.5M	20.8M	23.6M	27.1M	17.0M
Property Plant Equipment	1.6M	409.2K	612.4K	114.5K	131.6K	125.1K
Total Assets	3.8M	1.8M	2.0M	608.2K	95.6K	90.9K
Total Stockholder Equity	3.5M	1.5M	1.5M	261.2K	(334.7K)	(318.0K)
Cash	2.8M	624.2K	1.4M	536.8K	64.1K	60.9K
Non Current Assets Total	2.1M	416.7K	649.2K	144.9K	28.9K	0.0
Other Assets	489.9K	7.5K	36.9K	30.5K	27.4K	26.1K
Common Stock Shares Outstanding	39.5M	56.0M	79.1M	7.9M	7.1M	6.8M
Other Current Assets	5.0K	2.8K	30.1K	1.3K	1.2K	1.1K
Other Stockholder Equity	1.8M	1.8M	3.0M	3.2M	3.7M	2.7M
Total Liab	305.7K	361.9K	413.3K	346.9K	430.4K	355.3K
Net Invested Capital	3.5M	1.5M	1.5M	261.2K	(304.7K)	(289.5K)
Net Working Capital	3.3M	920.4K	1.4M	232.4K	(334.7K)	(318.0K)

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

When determining whether Beyond Medical Techn is a strong investment it is important to analyze Beyond Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beyond Medical's future performance. For an informed investment choice regarding Beyond Stock, refer to the following important reports:

How To Invest In Beyond

Details

Is Beyond Stock a good investment?

Details

What is Beyond Medical's Net Worth?

Details

Largest Industrial Machinery & Supplies & Components Companies

View

Largest Pollution & Treatment Controls Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Beyond Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.04)

Revenue Per Share

(0)

Quarterly Revenue Growth

(0.92)

Return On Assets

(2.19)

Return On Equity

(1.89)

The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Beyond Operating Income vs Selling General Administrative Analysis

Operating Income vs Selling General Administrative

Operating Income vs Selling General Administrative Correlation Analysis

Correlation Coefficient

Operating Income

Selling General Administrative

Beyond Medical fundamental ratios Correlations

Beyond Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Beyond Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Working Capital	+ 0.99	Total Assets
Net Working Capital	+ 0.99	Total Stockholder Equity
Short Term Investments	+ 0.99	Other Assets

Capital Lease Obligations	- 0.96	Capital Stock
Total Liab	- 0.96	Other Current Assets
Total Liab	- 0.96	Retained Earnings
Property Plant And Equipment Gross	- 0.95	Net Working Capital
Total Liab	- 0.95	Cash
Common Stock	- 0.95	Retained Earnings